Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage IB Pancreatic Adenocarcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT01192763
What this trial is testing

RO4929097 Before Surgery in Treating Patients With Pancreatic Cancer

Who this might be right for
Adenocarcinoma of the PancreasStage IA Pancreatic CancerStage IB Pancreatic Cancer+2 more
National Cancer Institute (NCI) 30
Early research (Phase 1)Study completedNCT01764477
What this trial is testing

Safety and Efficacy Study of PRI-724 Plus Gemcitabine in Subjects With Advanced or Metastatic Pancreatic Adenocarcinoma

Who this might be right for
Advanced Pancreatic CancerMetastatic Pancreatic CancerPancreatic Adenocarcinoma
Prism Pharma Co., Ltd. 20
Testing effectiveness (Phase 2)Temporarily pausedNCT05419479
What this trial is testing

Switch Maintenance in Pancreatic

Who this might be right for
Pancreatic CancerAdenocarcinoma of the PancreasSquamous Cell Carcinoma of Pancreas+1 more
James Cleary, MD, PhD 46
Testing effectiveness (Phase 2)UnknownNCT01182246
What this trial is testing

AXP107-11 in Combination With Standard Gemcitabine (Gemzar® ) Therapy for Treatment in Patients With Pancreatic Cancer

Who this might be right for
Adenocarcinoma
Axcentua Pharmaceuticals AB 44
Early research (Phase 1)Active Not RecruitingNCT03257761
What this trial is testing

Guadecitabine and Durvalumab in Treating Patients With Advanced Liver, Pancreatic, Bile Duct, or Gallbladder Cancer

Who this might be right for
Extrahepatic Bile Duct Adenocarcinoma, Biliary TypeGallbladder Adenocarcinoma, Biliary TypeMetastatic Pancreatic Adenocarcinoma+25 more
University of Southern California 55
Testing effectiveness (Phase 2)Study completedNCT02178436
What this trial is testing

Gemcitabine, Nab-paclitaxel and KPT-330 in Advanced Pancreatic Cancer

Who this might be right for
Acinar Cell Adenocarcinoma of the PancreasDuct Cell Adenocarcinoma of the PancreasStage IV Pancreatic Cancer
Mohammed Najeeb Al Hallak 15
Early research (Phase 1)Looking for participantsNCT06896188
What this trial is testing

9-ING-41 Combined With Retifanlimab, Plus Modified FOLFIRINOX for Patients With Advanced Pancreatic Adenocarcinoma (RiLEY)

Who this might be right for
Pancreatic Adenocarcinoma
Anwaar Saeed 12
Testing effectiveness (Phase 2)Ended earlyNCT03451773
What this trial is testing

M7824 (MSB0011359C) in Combination With Gemcitabine in Adults With Previously Treated Advanced Adenocarcinoma of the Pancreas

Who this might be right for
Cancer of PancreasPancreas CancerPancreatic Adenocarcinoma+2 more
National Cancer Institute (NCI) 7
Early research (Phase 1)Study completedNCT02077933
What this trial is testing

Study of Safety and Efficacy of Alpelisib With Everolimus or Alpelisib With Everolimus and Exemestane in Advanced Breast Cancer Patients, Renal Cell Cancer and Pancreatic Tumors

Who this might be right for
NeoplasmsBreast NeoplasmsKidney Neoplasms+1 more
Novartis Pharmaceuticals 79
Early research (Phase 1)Ended earlyNCT03549000
What this trial is testing

A Phase I/Ib Study of NZV930 Alone and in Combination With PDR001 and /or NIR178 in Patients With Advanced Malignancies.

Who this might be right for
Non-small Cell Lung Cancer (NSCLC)Triple Negative Breast Cancer (TNBC)Pancreatic Ductal Adenocarcinoma (PDAC)+4 more
Novartis Pharmaceuticals 127
Testing effectiveness (Phase 2)Active Not RecruitingNCT04140526
What this trial is testing

Safety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLC

Who this might be right for
Non Small Cell Lung CancerAdvanced Solid TumorMetastatic Melanoma+16 more
OncoC4, Inc. 733
Testing effectiveness (Phase 2)Ended earlyNCT02423954
What this trial is testing

Study of Nivolumab Plus Chemotherapy in Patients With Advanced Cancer (NivoPlus)

Who this might be right for
Advanced CancerPancreatic CancerRenal Cell Cancer+4 more
Western Regional Medical Center 33
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07665684
What this trial is testing

Samuraciclib in Combination With Gemcitabine/Nab-Paclitaxel in Patients With Metastatic Basal-Like Pancreatic Cancer

Who this might be right for
Pancreas Ductal AdenocarcinomaPancreas Cancer, MetastaticPancreatic Adenocarcinoma Metastatic+2 more
University Health Network, Toronto 67
Early research (Phase 1)Study completedNCT01487785
What this trial is testing

Dose-escalation, and Safety Study of LDE225 and Gemcitabine in Locally Advanced or Metastatic Pancreatic Cancer Patients

Who this might be right for
Pancreatic Cancer
Novartis Pharmaceuticals 18
Testing effectiveness (Phase 2)Study completedNCT01416662
What this trial is testing

Gemcitabine Hydrochloride in Treating Patients With Pancreatic Cancer That Has Been Removed by Surgery

Who this might be right for
Pancreatic Cancer
Federation Francophone de Cancerologie Digestive 120
Testing effectiveness (Phase 2)Study completedNCT02005419
What this trial is testing

Metformin Combined With Gemcitabine as Adjuvant Therapy for Pancreatic Cancer After Curative Resection

Who this might be right for
Stage IA Pancreatic AdenocarcinomaStage IB Pancreatic AdenocarcinomaStage IIA Pancreatic Adenocarcinoma+1 more
Xian-Jun Yu 300
Early research (Phase 1)Study completedNCT03373188
What this trial is testing

VX15/2503 and Immunotherapy in Resectable Pancreatic and Colorectal Cancer

Who this might be right for
Colon Carcinoma Metastatic in the LiverColorectal AdenocarcinomaPancreatic Adenocarcinoma+11 more
Emory University 10
Testing effectiveness (Phase 2)Study completedNCT03745430
What this trial is testing

RAmucirumab Combined wIth Standard Nab-paclitaxel and Gemcitabine as First-line Chemotherapy in Patients With Advanced Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic Adenocarcinoma
Hellenic Cooperative Oncology Group 54
Early research (Phase 1)Looking for participantsNCT06182072
What this trial is testing

ProAgio in Pancreatic Ductal Adenocarcinoma (PDAC)

Who this might be right for
Pancreatic Ductal Adenocarcinoma (PDAC)
ProDa BioTech, LLC 46
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07477418
What this trial is testing

PDAC Regression and Intraoperative Surgical Margin With Neoadjuvant TAMP (PRISM-TAMP)

Who this might be right for
Pancreatic Ductal Adenocarcinoma (PDAC)Borderline Resectable Pancreatic CancerPancreatic Neoplasms
University of Vermont 10
Next Page